Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Kalif Eliyahu Sharon
(EVP, Chief Financial Officer) |
S | Ordinary Shares | D | 77550 | $13.52 - $13.52 | $1,048,119 |
2024-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Conway Vikki L
(See "Remarks") |
S | Ordinary Shares | D | 1427 | $13.52 - $13.52 | $19,286 |
2024-03-04 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Conway Vikki L
(See "Remarks") |
S | Ordinary Shares | D | 3532 | $13.37 - $13.37 | $47,234 |
2024-03-04 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Francis Richard D
(President and CEO) |
S | Ordinary Shares | D | 31061 | $13.34 - $13.34 | $414,269 |
2024-02-28 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Drape Eric
(Executive VP Global Operations) |
S | Ordinary Shares | D | 9815 | $13.12 - $13.12 | $128,733 |
2024-02-28 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Daniell Richard
(Exec. VP, European Commercial) |
S | Ordinary Shares | D | 20599 | $13.12 - $13.12 | $270,176 |
2024-02-28 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Conway Vikki L
(See "Remarks") |
S | Ordinary Shares | D | 1366 | $13.12 - $13.12 | $17,916 |
2024-02-16 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Drape Eric
(Executive VP Global Operations) |
S | Ordinary Shares | D | 173261 | $13.05 - $13.05 | $2,261,905 |
2024-02-15 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Francis Richard D
(President and CEO) |
S | Ordinary Shares | D | 74530 | $13.15 - $13.15 | $980,173 |
2024-02-01 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir
(Chief Accounting Officer) |
S | Ordinary Shares | D | 31766 | $12.37 - $12.37 | $392,954 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |